Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 29, 2018	Mar. 31, 2018
Assets
Cash and cash equivalents	$ 21,943	$ 35,600
Accounts receivable, net of allowance for doubtful accounts of $2,454 and $2,982	104,009	99,150
Inventories, net	19,954	26,107
Costs/estimated earnings in excess of billings on uncompleted contracts	50,826	52,696
Other current assets	30,682	26,113
Current assets held for sale	151	47,176
Total current assets	227,565	286,842
Property, plant and equipment, net	19,555	23,152
Intangibles, net	35,414	39,145
Deferred tax asset	4,221	6,474
Other non-current assets	11,009	8,444
Non-current assets held for sale	0	12,278
Total assets	297,764	376,335
Liabilities
Accounts payable	43,950	49,243
Accrued compensation and benefits	13,897	15,823
Deferred revenue	23,904	27,420
Billings in excess of costs/estimated earnings on uncompleted contracts	12,176	12,547
Short-term debt		157,500
Other current liabilities	26,323	25,905
Current liabilities held for sale	0	20,597
Total current liabilities	221,790	309,035
Long-term debt	328	477
Other non-current liabilities	15,701	15,884
Non-current liabilities held for sale	0	597
Total liabilities	237,819	325,993
Stockholders’ equity
Preferred stock authorized 5,000, par value $1.00, none issued	0	0
Common stock authorized 100,000, par value $.001, 15,238 and 15,141 shares outstanding, 27,026 and 26,880 issued	26	26
Additional paid-in capital	511,429	509,960
Retained earnings	(22,842)	(35,664)
Accumulated other comprehensive income (loss)	(12,568)	(7,992)
Treasury stock, at cost 11,788 and 11,740 shares	(416,100)	(415,988)
Total stockholders’ equity	59,945	50,342
Total liabilities and stockholders’ equity	$ 297,764	$ 376,335